A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Despite its beneficial effect, ureteral stents may produce symptoms (such as hematuria, dysuria, frequency, urgency, urge incontinence and suprapubic or flank pain) that affect the quality of life in 70-80%. This study will be conducted to evaluate the role of Phosphodiestrase 5 inhibitor (Sildenafil Citrate) in relieving these symptoms.
Epistemonikos ID: 1c3fb58e5965c16a3555f9d6be0d93fdcbcf4c25
First added on: May 12, 2024